Abolis

Paris, France · Privately Held (backing)

Developer of a microbial biotechnology platform designed to change production models of high-value molecules. Abolis is based in Paris, France. Its last known valuation is $53.1 million. It has raised $40.1 million.

Last price · $/share
—
Implied valuation
$53.1M
Total raised
$40.1M
Last round
—
What is Abolis worth?
$53.1Mlast known valuation
Free account
More of Abolis with a free account
  • ·Watch Abolis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Abolis funding history

No rounds on record

No funding rounds for Abolis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Abolis valuation

Abolis's last known valuation is $53.1 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Abolis's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Abolis, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Abolis

What is Abolis worth?
Abolis's last known valuation is $53.1M.
How much has Abolis raised?
Abolis has raised $40.1M in total funding across its recorded rounds.